Due to amino acid differences at antibody binding sites in two venetoclax-sensitive DLBCL lines, SUDHL4 and SUDHL6, two BCL2 antibodies were needed to detect BCL2 (Figure 1B, Supplementary Table S1). Here, BCL2 is linked to diffuse large B-cell lymphoma.